The National Institute of Allergy and Infectious Diseases (NIAID) has launched a 7-year, multimillion-dollar research initiative to find new ways to selectively silence the immune system cells that play a role in autoimmune diseases and the rejection of transplanted organs. The project will link nearly 40 centers around the world in the Collaborative Network for Clinical Research on Immune Tolerance.
The collaborative effort "flows from NIAID's plan to accelerate clinical trials for novel approaches to modulate immune responses," said NIAID Director Anthony S. Fauci, MD. The Juvenile Diabetes Foundation International will supply an additional $14 million, and the National Institute of Diabetes and Digestive and Kidney Diseases is also contributing to the effort.
Stephenson J. Inducing Immune Tolerance. JAMA. 1999;282(23):2201. doi:10.1001/jama.282.23.2201-JHA90010-4-1
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: